共 8 条
[3]
Lipoprotein-Associated Phospholipase A2 and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction) Trial[J] . Michelle O’Donoghue,David A. Morrow,Marc S. Sabatine,Sabina A. Murphy,Carolyn H. McCabe,Christopher P. Cannon,Eugene Braunwald.Circulation . 2006 (14)
[4]
Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke: The Rotterdam Study[J] . Hok-Hay S. Oei,Irene M. van der Meer,Albert Hofman,Peter J. Koudstaal,Theo Stijnen,Monique M.B. Breteler,Jacqueline C.M. Witteman.Circulation . 2005 (5)
[5]
CLINICAL REVIEW: Lipoprotein-Associated Phospholipase A2, a Novel Inflammatory Biomarker and Independent Risk Predictor for Cardiovascular Disease[J] . Krishnankutty Sudhir.The Journal of Clinical Endocrinology & Metabolism . 2005 (5)
[6]
Platelet-Activating Factor Acetylhydrolase Activity Indicates Angiographic Coronary Artery Disease Independently of Systemic Inflammation and Other Risk Factors: The Ludwigshafen Risk and Cardiovascular Health Study[J] . Circulation . 2005 (8)
[7]
Lipoprotein-associatedphospholipase A2 protein expression in the natural progression ofhuman coronary atherosclerosis. Kolodgie FD,Burke AP,Skorija KS,et al. Arteriosclerosis and Thrombosis . 2006
[8]
Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors,markers of inflammation,renal function,and hemodynamic stress. Koenig W,Twardella D,Brenner H,et al. Arteriosclerosis and Thrombosis . 2006